Certain antivirals help slow or stop a virus from replicating and thereby help reduce the symptoms associated with COVID-19 and the risk of significant health complications. The Pfizer investigational antiviral compound is a type of compound called a protease inhibitor, which interferes with part of the coronavirus needed for the virus to make copies of itself. This compound is currently being investigated for potential treatment of COVID-19.